(GDS) Ramsay Generale De Sante - Ratings and Ratios
Exchange: PA • Country: France • Currency: EUR • Type: Common Stock • ISIN: FR0000044471
GDS: Healthcare, Hospitals, Clinics, Medical, Services
Ramsay Générale de Santé SA operates healthcare facilities in France, Sweden, Norway, Denmark, and Italy. The company operates proximity care centers, and clinics and specialized hospitals; and provides primary medicine, medicine surgery obstetrics (MSO) dialysis, oncology, medical imaging, medical care, follow-up and rehabilitation care, home care and hospitalization, mental health care, and addiction treatment, telemedicine e health, elderly, emergency, maternity, nutrition, obesity and eating disorders, sanitary transport, outpatient surgery and eras, and SMR services. Ramsay Générale de Santé SA was formerly known as Générale de Santé SA and changed its name to Ramsay Générale de Santé SA in December 2015. The company was founded in 1987 and is headquartered in Paris, France. Ramsay Générale de Santé SA operates as a subsidiary of Ramsay Health Care Limited. Web URL: https://www.ramsaygds.fr
Additional Sources for GDS Stock
GDS Stock Overview
| Market Cap in USD | 1,372m |
| Sector | Healthcare |
| Industry | Medical Care Facilities |
| GiC Sub-Industry | Health Care Facilities |
| IPO / Inception |
GDS Stock Ratings
| Growth 5y | -52.9% |
| Fundamental | 4.61% |
| Dividend | 11.6% |
| Rel. Strength Industry | -45.3 |
| Analysts | - |
| Fair Price Momentum | 9.13 EUR |
| Fair Price DCF | 94.44 EUR |
GDS Dividends
| Dividend Yield 12m | 0.00% |
| Yield on Cost 5y | % |
| Annual Growth 5y | 0.00% |
| Payout Consistency | 38.6% |
GDS Growth Ratios
| Growth Correlation 3m | -29.2% |
| Growth Correlation 12m | -65.8% |
| Growth Correlation 5y | -21.1% |
| CAGR 5y | -10.03% |
| CAGR/Mean DD 5y | -0.48 |
| Sharpe Ratio 12m | -1.52 |
| Alpha | -50.87 |
| Beta | 0.23 |
| Volatility | 67.19% |
| Current Volume | 0.2k |
| Average Volume 20d | 2.8k |
What is the price of GDS stocks?
As of January 30, 2025, the stock is trading at EUR 10.70 with a total of 203 shares traded.
Over the past week, the price has changed by -6.96%, over one month by -11.57%, over three months by -18.94% and over the past year by -42.32%.
As of January 30, 2025, the stock is trading at EUR 10.70 with a total of 203 shares traded.
Over the past week, the price has changed by -6.96%, over one month by -11.57%, over three months by -18.94% and over the past year by -42.32%.
Is Ramsay Generale De Sante a good stock to buy?
Neither. Based on ValueRay Fundamental Analyses, Ramsay Generale De Sante is currently (January 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 4.61 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of GDS as of January 2025 is 9.13. This means that GDS is currently overvalued and has a potential downside of -14.67%.
Neither. Based on ValueRay Fundamental Analyses, Ramsay Generale De Sante is currently (January 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 4.61 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of GDS as of January 2025 is 9.13. This means that GDS is currently overvalued and has a potential downside of -14.67%.
Is GDS a buy, sell or hold?
Ramsay Generale De Sante has no consensus analysts rating.
Ramsay Generale De Sante has no consensus analysts rating.
What are the forecast for GDS stock price target?
According to ValueRays Forecast Model, GDS Ramsay Generale De Sante will be worth about 9.9 in January 2026. The stock is currently trading at 10.70. This means that the stock has a potential downside of -7.2%.
According to ValueRays Forecast Model, GDS Ramsay Generale De Sante will be worth about 9.9 in January 2026. The stock is currently trading at 10.70. This means that the stock has a potential downside of -7.2%.
| Issuer | Forecast | Upside |
|---|---|---|
| Wallstreet Target Price | 19.1 | 78.8% |
| Analysts Target Price | - | - |
| ValueRay Target Price | 9.9 | -7.2% |